n-(2-hydroxypropyl)methacrylamide has been researched along with Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JH; Nan, A; Sabnis, G | 1 |
| Avaritt, BR; Bareford, LM; Ghandehari, H; Nan, A; Swaan, PW | 1 |
| Bazan-Peregrino, M; Carlisle, R; Choi, J; Coussios, CC; Kostka, L; Laga, R; Seymour, LW; Subr, V; Ulbrich, K | 1 |
| David, A; Feinshtein, V; Zaiden, M | 1 |
| Barz, M; Kabanov, AV; Luxenhofer, R; Zentel, R | 1 |
| Rihova, B | 1 |
| Benayoun, L; Eldar-Boock, A; Miller, K; Polyak, D; Satchi-Fainaro, R; Segal, E; Shaked, Y | 1 |
7 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Breast Cancer
| Article | Year |
|---|---|
Synthesis and in vitro characterization of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]-trastuzumab conjugates targeted to breast cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Drug Delivery Systems; Female; Humans; Mitogen-Activated Protein Kinases; Polymethacrylic Acids; Receptor, ErbB-2; Trastuzumab; Tumor Cells, Cultured | 2012 |
Riboflavin-targeted polymer conjugates for breast tumor delivery.
Topics: Acrylamides; Antibiotics, Antineoplastic; Breast; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Endocytosis; Female; Humans; Mitomycin; Riboflavin | 2013 |
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
Topics: Acrylamides; Adenoviridae; Adjuvants, Pharmaceutic; Analysis of Variance; Animals; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Microbubbles; Oncolytic Virotherapy; Oncolytic Viruses; Pharmaceutical Vehicles; Ultrasonic Therapy; Xenograft Model Antitumor Assays | 2013 |
Inhibition of CD44v3 and CD44v6 function blocks tumor invasion and metastatic colonization.
Topics: Acrylamides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Drug Delivery Systems; Female; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Prostatic Neoplasms; Tissue Distribution | 2017 |
The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells.
Topics: Acrylamides; Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Materials Testing; Polymers | 2009 |
Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates.
Topics: Acrylamides; Adult; Animals; Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Epirubicin; Female; Hemangiosarcoma; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunologic Factors; Middle Aged; Neoplasm Metastasis; Polymethacrylic Acids; Quality of Life; Treatment Outcome | 2009 |
Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.
Topics: Acrylamides; Alendronate; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Flow Cytometry; Humans; Immunohistochemistry; Leukocyte Count; Mice; Mice, Inbred BALB C; Paclitaxel | 2011 |